• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Aug27
CICC Raises Target Price for Ocuvita Biotech to HKD 10.16
03:15
Aug25
Ocumetrix Biotech Sees Significant Revenue Growth in 2025 H1
02:32
Aug21
OCUMENSION-B released FY2025 Q1 earnings on August 21, 2025 (BJT) with actual revenue of HKD 157.45 M and EPS of HKD -0.0897
15:00
Oculeve's OT-301 drug reaches primary endpoint in Phase III clinical trial
11:52
OCUMENSION-B released FY2025 Q2 earnings on August 21 During-Market (BJT), actual revenue HKD 160.91 M, actual EPS HKD -0.0917
08:00
OCUMENSION-B released FY2025 Semi-Annual Earnings on August 21 During-Market (BJT), actual revenue HKD 318.36 M (forecast HKD 347.7 M), actual EPS HKD -0.1815 (forecast HKD -0.1313)
08:00

Schedules & Filings

Schedules
Filings
Aug21
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 160.91 M, Net Income -72.41 M, EPS -0.0917

Mar31
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 132.81 M, Net Income -62.2 M, EPS -0.0878

Aug12
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 90.06 M, Net Income -81.31 M, EPS -0.1235

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
01792
0.059
+103.45%
+0.030
02971
0.025
+78.57%
+0.011
08125
0.375
+44.23%
+0.115
01380
0.670
+38.14%
+0.185
01552
0.275
+36.14%
+0.073
08305
0.385
+35.09%
+0.100
01633
0.116
+27.47%
+0.025
00162
0.057
+26.67%
+0.012
01163
0.179
+26.06%
+0.037
02336
0.247
+24.12%
+0.048
View More